Physician profile
Peter Davis
NPI 1033525662
$1,067.56
in general payments reported to CMS, 2019-2025
16 companies · $370 in 2025
The $370 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $284 · 2023: $136 · 2024: $148 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $248.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Baxter Healthcare | $155.77 | 2022 | |
| Medtronic, INC. | $146.95 | 2021-2023 | Eea, Interstim |
| Integra Lifesciences Corporation | $119.91 | 2021-2024 | Integra, Surgimend, Omnigraft |
| Hologic Sales and Service, LLC | $113.68 | 2022-2025 | Fluent Fluid Management System, Coolseal Generator, Omni Hysteroscope |
| Braintree Laboratories, INC. | $95.84 | 2021-2025 | Suflave, Sutab |
| Axonics, INC. | $34.03 | 2023 | Axonics |
| Solventum Corporation | $23.56 | 2024 | Prevena, Activ.A.C. Ion Progress, V.A.C. Veraflo Cleanse Choice |
| Ethicon US, LLC | $23.38 | 2022 | |
| Teleflex LLC | $21.13 | 2025 | Barrigel |
| Aroa Biosurgery Incorporated | $19.46 | 2023 | |
| Coloplast Corp | $18.36 | 2025 | |
| Acera Surgical, INC. | $16.50 | 2025 | Restrata Wound Matrix |
| Takeda Pharmaceuticals U.S.A., INC. | $14.40 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.87 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.